Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

Vita 34 AG. (5/16/12). "Press Release: Vita 34 Strengthens Biotechnology Sector by Company Takeover and Announces Change in Management Board". Leipzig.

Region Region Germany
Organisations Organisation Vita 34 AG
  Group Vita 34 (Group)
  Organisation 2 BioPlanta GmbH
  Group Vita 34 (Group)
Product Product plant biotechnology
Index term Index term BioPlanta–Vita 34: investment, 201205 acquisition in shares with 380k new shares issued to BioPlanta owner + founder André Gerth
Persons Person Gerth, André (BioPlanta 201106 Managing Director)
  Person 2 Lampeter, Eberhard F. (Vita 34 1997–201205 Chairman of Management Board RESIGNED 6/12)
     


The VITA 34 AG (ISIN DE000A0BL849), the oldest private umbilical cord blood bank in the German-speaking countries takes over the biotechnology specialist BioPlanta GmbH and announces a change in the management board. This is the first German takeover made by VITA 34.

Today, VITA 34 has concluded a contribution agreement on the acquisition of shares in the BioPlanta GmbH. BioPlanta possesses an innovative technology to produce active herbal ingredients for the environmental and pharmaceutical sectors. The company, which was founded 20 years ago, operates on a global basis in Chile, Mexico, Vietnam, China and other countries. BioPlanta has produced a revenue of about 1.5 million Euros in 2011 and has been working profitably for years. By means of this takeover, VITA 34 wants to make use of synergies in the biotechnological sector and extend its value chain, for instance by developing more business segments also outside of Europe. VITA 34 has been working with BioPlanta since 2011 within the scope of a research project to develop a method to produce antifreeze proteins in plant bioreactors and their application in the cryo-preservation of stem cells.

The shares are taken over by means of an increase in capital stock from the authorized stock of the VITA 34 AG against contributions in kind. For this purpose, VITA 34 will issue a total of 380,000 new no-par value registered shares in the company at a nominal share in the company's authorized capital of EUR 1.00 respectively. The new shares will be exclusively subscribed for by the current owner of the BioPlanta shares, Dr. André Gerth.

Dr. med. Eberhard F. Lampeter is going to resign from his position as a chairman of the management board of the VITA 34 AG and withdraw from the management board. He will continue to work for the company in the future as a medical consultant and in all scientific projects of the VITA 34 AG. Dr. Lampeter has led VITA 34 from its formation to the present-day medical and scientific reputation and strong market position.

Dr. Gerth will be appointed as a member of the company's management board with effect from June 1, 2012. He will be responsible for the operational business and foreign activities of the VITA 34 AG. The 48-year-old founder and CEO of BioPlanta has many years of experience and expert knowledge in the field of biotechnology and project management and a broad international contact network.


Press/ Investor Relations:

Axel Mühlhaus
Peggy Kropmanns
edicto GmbH
Eschersheimer Landstr. 42-44
D-60322 Frankfurt

Phone: +49 (069) 90550550
Fax: +49 (069) 90550577
E-mail: vita34@edicto.de

   
Record changed: 2017-04-02

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Vita 34 (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px




» top